P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy.

Support Care Cancer · 2024 · PMC11180022 · PMID 38879700

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

near-significantp =0.06so close (0.05 < p ≤ 0.1)

Additionally, within-group analysis revealed a near-significant increase from t0 to t2 in the IG (t0 median 17.25, t2 median 23.00, Z =-2.731, p =0.06).

also in 1,169 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.